Which inflammatory marker, between systemic immune-inflammation index and neutrophil to eosinophil ratio, is associated with Peyronie's disease and are there any implications for a better understanding of its mechanisms?

Journal Information

Full Title: Basic Clin Androl

Abbreviation: Basic Clin Androl

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Andrology

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Transparency Score
3/6
50.0% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Data Sharing
Code Sharing
Evidence found in paper:

"Declarations Ethics approval and consent to participateEthical review and approval were not required for the study on human participants in accordance with the local legislation and institutional requirements. Written informed consent for participation was not required for this study in accordance with the national legislation and the institutional requirements. Consent for publicationWritten informed consent for publications was obtained from subjects involved in the study. Competing interestsAll authors have no conflict of interest.All have no direct or indirect commercial financial incentive associated with publishing the article.No financial support has been received for this research/study.No funding agreement limits our ability fairly to complete and publish our research/study. Competing interests All authors have no conflict of interest. All have no direct or indirect commercial financial incentive associated with publishing the article. No financial support has been received for this research/study. No funding agreement limits our ability fairly to complete and publish our research/study."

Evidence found in paper:

"Funding This research received no funding."

Protocol Registration
Open Access
Paper is freely available to read
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025